🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James P. Dean

AbbVie (United States)

ORCID: 0000-0001-8058-1682
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study”.

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2856
N/A
4.5DataRank · unranked
184 citations

Richard R. Furman, Steven Coutré, Ian W. Flinn, Jan A. Burger, Kristie A. Blum +9 more

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

British Journal of Haematology(2021)10.1111/bjh.17984
N/A
2.2DataRank · unranked
64 citations

Tait D. Shanafelt, Adrian Wiestner, Carol Moreno, Susan O’Brien, Jianling Li +4 more

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3887
N/A
0DataRank · unranked
17 citations

Paolo Ghia, John C. Byrd, Inhye E. Ahn, Carol Moreno, Susan O’Brien +8 more

Relapse after First-Line Fixed Duration Ibrutinib + Venetoclax: High Response Rates to Ibrutinib Retreatment and Absence of BTK Mutations in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) with up to 5 Years of Follow-up in the Phase 2 Captivate Study

Blood(2023)10.1182/blood-2023-187128
N/A
0DataRank · unranked
39 citations

William G. Wierda, Paul M. Barr, Thomas J. Kipps, Tanya Siddiqi, John N. Allan +6 more